BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19535169)

  • 41. Acute exacerbation of preexisting interstitial lung disease after administration of etanercept for rheumatoid arthritis.
    Hagiwara K; Sato T; Takagi-Kobayashi S; Hasegawa S; Shigihara N; Akiyama O
    J Rheumatol; 2007 May; 34(5):1151-4. PubMed ID: 17444583
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate.
    Genovese MC; Cohen S; Moreland L; Lium D; Robbins S; Newmark R; Bekker P;
    Arthritis Rheum; 2004 May; 50(5):1412-9. PubMed ID: 15146410
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis.
    Brandt J; Listing J; Haibel H; Sörensen H; Schwebig A; Rudwaleit M; Sieper J; Braun J
    Rheumatology (Oxford); 2005 Mar; 44(3):342-8. PubMed ID: 15561737
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-TNF therapies in the management of acute and chronic uveitis.
    Hale S; Lightman S
    Cytokine; 2006 Feb; 33(4):231-7. PubMed ID: 16542849
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy.
    Gottenberg JE; Merle-Vincent F; Bentaberry F; Allanore Y; Berenbaum F; Fautrel B; Combe B; Durbach A; Sibilia J; Dougados M; Mariette X
    Arthritis Rheum; 2003 Jul; 48(7):2019-24. PubMed ID: 12847696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks.
    Davis JC; van der Heijde DM; Braun J; Dougados M; Cush J; Clegg D; Inman RD; Kivitz A; Zhou L; Solinger A; Tsuji W
    Ann Rheum Dis; 2005 Nov; 64(11):1557-62. PubMed ID: 15843448
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Recurrent new-onset uveitis in a patient with rheumatoid arthritis during anti-TNFalpha treatment].
    Di Gangi M; Foti R; Leonardi R; Leonetti C; Castellino P
    Reumatismo; 2007; 59(2):169-72. PubMed ID: 17603697
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Etanercept in arthritis.
    Scott DL
    Int J Clin Pract; 2005 Jan; 59(1):114-8. PubMed ID: 15707475
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Etanercept-associated pulmonary granulomatous inflammation in patients with rheumatoid arthritis.
    Ognenovski VM; Ojo TC; Fox DA
    J Rheumatol; 2008 Nov; 35(11):2279-82. PubMed ID: 19004058
    [No Abstract]   [Full Text] [Related]  

  • 50. Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series.
    Cohen JD; Bournerias I; Buffard V; Paufler A; Chevalier X; Bagot M; Claudepierre P
    J Rheumatol; 2007 Feb; 34(2):380-5. PubMed ID: 17013997
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [TNF blockade in rheumatoid arthritis can cause severe fibrosing alveolitis. Six case reports].
    Tengstrand B; Ernestam S; Engvall IL; Rydvald Y; Hafström I
    Lakartidningen; 2005 Dec 5-11; 102(49):3788-90, 3793. PubMed ID: 16408702
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Uveitis associated with sarcoidosis exacerbated by etanercept therapy.
    Suzuki J; Goto H
    Jpn J Ophthalmol; 2009 Jul; 53(4):439-40. PubMed ID: 19763766
    [No Abstract]   [Full Text] [Related]  

  • 53. Tuberculous uveitis after treatment with etanercept.
    Fonollosa A; Segura A; Giralt J; Garcia-Arumi J
    Graefes Arch Clin Exp Ophthalmol; 2007 Sep; 245(9):1397-9. PubMed ID: 17364199
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Leukopenia and thrombocytopenia induced by etanercept: two case reports and literature review.
    Azevedo VF; Silva MB; Marinello DK; Santos FD; Silva GB
    Rev Bras Reumatol; 2012; 52(1):110-2. PubMed ID: 22286650
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Scurvy as the presenting illness of Whipple's disease exacerbated by treatment with etanercept in a patient with ankylosing spondylitis.
    Hmamouchi I; Costes V; Combe B; Morel J
    J Rheumatol; 2010 May; 37(5):1077-8. PubMed ID: 20439534
    [No Abstract]   [Full Text] [Related]  

  • 56. Towards the next generation of anti-TNF drugs.
    Sfikakis PP; Tsokos GC
    Clin Immunol; 2011 Dec; 141(3):231-5. PubMed ID: 22004846
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A case of panuveitis with optic disc neovascularization associated with juvenile idiopathic arthritis which progressed during a clinical trial of etanercept].
    Kinouchi R; Hirokawa H; Igarashi S; Fukui K; Hirano Y; Takai Y; Yoshida A
    Nippon Ganka Gakkai Zasshi; 2007 Dec; 111(12):970-5. PubMed ID: 18186220
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Etanercept-associated episcleritis: a pediatric case report of a paradoxical adverse reaction and review of the literature.
    Küçükali B; Gezgin Yıldırım D; Esmeray Şenol P; Özdemir HB; Bakkaloğlu SA
    Clin Rheumatol; 2024 Feb; 43(2):799-808. PubMed ID: 37845415
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enbrel-induced interstitial lung disease.
    Quintos-Macasa AM; Quinet R
    South Med J; 2006 Jul; 99(7):783-4. PubMed ID: 16866070
    [No Abstract]   [Full Text] [Related]  

  • 60. Etanercept therapy-associated acute uveitis: a case report and literature review.
    Wang F; Wang NS
    Clin Exp Rheumatol; 2009; 27(5):838-9. PubMed ID: 19917170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.